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II is secreted into the lumens of proximal tubules where it is also
synthesized, thus increasing the local concentration of the peptide to
levels of potential physiological relevance. In the present work, we
studied the effect of ANG II via the luminal membranes of LLC-PK1
cells on Ca2-ATPase of the sarco(endo)plasmic reticulum (SERCA)
and plasma membrane (PMCA). ANG II (at concentrations found in
the lumen) stimulated rapid (30 s) and persistent (30 min) SERCA
activity by more than 100% and increased Ca2 mobilization. Pre-
treatment with ANG II for 30 min enhanced the ANG II-induced Ca2
spark, demonstrating a positively self-sustained stimulus of Ca2
mobilization by ANG II. ANG II in the medium facing the luminal
side of the cells decreased with time with no formation of metabolites,
indicating peptide internalization. ANG II increased heterodimeriza-
tion of AT1 and AT2 receptors by 140%, and either losartan or
PD123319 completely blocked the stimulation of SERCA by ANG II.
Using the PLC inhibitor U73122, PMA, and calphostin C, it was
possible to demonstrate the involvement of a PLC¡DAG(PMA)¡PKC
pathway in the stimulation of SERCA by ANG II with no effect on
PMCA. We conclude that ANG II triggers SERCA activation via the
luminal membrane, increasing the Ca2 stock in the reticulum to
ensure a more efficient subsequent mobilization of Ca2. This first
report on the regulation of SERCA activity by ANG II shows a new
mechanism for Ca2 homeostasis in renal cells and also for
regulation of Ca2-modulated fluid reabsorption in proximal tu-
bules.
luminal effect of ANG II; Ca2 sparks; proximal tubule Ca2 ho-
meostasis; fluid reabsorption
THE KIDNEY IS an essential organ in homeostasis and body fluid
regulation. Its functions are modulated by different hormones
and autacoids that act on hydroelectrolytic balance, extracel-
lular volume, and blood pressure, such as angiotensin II (ANG
II) (24). ANG II plays a crucial role in renal Ca2 handling,
one of the main cell messengers (4, 5, 13, 51), which is
involved in the fine tuning of fluid reabsorption in different
segments of the nephron (17). Approximately 60% of the
plasma Ca2 is filtered by the kidneys, 99% of which is
reabsorbed (70% of it in the proximal tubules) (19). ANG II
regulates Ca2 reabsorption in both luminal and basolateral
aspects of tubule membranes (4, 5, 13). In proximal tubule
cells, intracellular Ca2 mobilization activates Ca2-depen-
dent intracellular signaling pathways, including those associ-
ated with ANG II-modulated Na and water reabsorption
mechanisms (8, 16, 17, 39, 42).
Active and passive transport mechanisms participate in Ca2
reabsorption in the proximal tubules (19, 48). Concerning
primary active transporters, there are two main Ca2-ATPase
subfamilies in proximal tubule cells, the sarco(endo)plasmic
reticulum Ca2-ATPase (SERCA) and the plasma membrane
Ca2-ATPase (PMCA) (38). These pumps control intracellular
Ca2 concentration by regulating intracellular Ca2 stocks,
fine-tuning cytosolic Ca2 activity in many cell types (12).
Therefore, renal SERCA and PMCA are excellent targets for
hormones, including ANG II and angiotensin-derived peptides
(6). We found that picomolar ANG II inhibits PMCA activity
via a PLC/protein kinase C (PKC) pathway triggered by the
peptide binding to AT1R/AT2R heterodimers (4, 5). Micromo-
lar ANG II is metabolized by peptidases associated with the
basolateral membrane, generating Ang-(3–4) that reactivates
PMCA (5, 6).
Classically, ANG II was described to be formed only sys-
temically. Different studies in the last two decades found that
ANG II is formed in different tissues such as brain, heart, and
adipose tissue (7, 18, 34) and, especially, in kidney, where
local renin-angiotensin system was first described (10, 20, 25,
26, 28, 50). Because of this local synthesis, ANG II levels are
much higher in the kidney than in plasma (37, 43), being found
in proximal tubule fluid in the nanomolar range (9, 23, 36, 43).
This tubular fluid ANG II is not only derived from the filtrate
but is also secreted into the lumen by proximal tubule cells
(37). Alternatively, angiotensinogen or ANG I may be secreted
into the proximal tubule and converted to ANG II by the
brush-border angiotensin-converting enzyme (ACE) (15, 27,
35, 37, 40). Intratubular ANG II synthesis indicates that lumi-
nal ANG II effects are also as important as its interstitial
effects. ANG II AT1R and AT2R are also expressed in different
nephron segments, including the basolateral and luminal mem-
branes of proximal tubule cells (32, 44, 49), and in organelles
of renal cells (14, 52).
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Due to the high ANG II concentrations in proximal luminal
fluid and the importance of Ca2 in water and solutes in
proximal reabsorption, we investigated whether exposition of
the luminal membrane side to ANG II modulates SERCA and
PMCA activities in an immortalized lineage of proximal tubule
cells from pig kidney (LLC-PK1 cells). We found that AT1R/
AT2R heterodimers participate in an ANG II-mediated signal-
ing pathway starting from the luminal side that culminates in
an increase in SERCA turnover.
METHODS
Material. A Neubauer chamber (Boeco, Hamburg, Germany) was
used for cell counting. Low-glucose DMEM supplemented with
penicillin (100 U/ml) and streptomycin (100 g/ml), FBS, and trypsin
solution (0.25% trypsin plus 0.04% EDTA-tetrasodium salt) was
obtained from GIBCO (Invitrogen Life Technologies, Carlsbad, CA).
Distilled water deionized through Milli-Q resins (Millipore) was used
to prepare solutions. 32Pi was obtained from the Brazilian Institute of
Energy and Nuclear Research (IPEN, São Paulo, Brazil). Labeled
[-32P]ATP was obtained as in Ref. 30. Acetonitrile and trifluoro-
acetic acid were from TEDIA Brasil (Rio de Janeiro, RJ). Protein
A/G-agarose, anti-AT1R, and anti-AT2R antibodies were from Santa
Cruz Biotechnology (Santa Cruz, CA). Losartan was obtained from
Merck Sharp & Dohme (Whitehouse Station, NJ). LLC-PK1 cells
(American Type Culture Collection) were kindly provided by Dr.
Celso Caruso-Neves. Trypan blue solution 1% (wt/vol), trypsin in-
hibitor (type II-S soybean), bovine serum albumin, ouabain,
PD123319, buffers, and ANG II were obtained from Sigma (St. Louis,
MO). All other reagents were of the highest purity available.
Renal epithelial cell culture. LLC-PK1 cells were grown in low-
glucose DMEM (10% FBS) with antibiotic supplements in a humid-
ified atmosphere of 5% CO2 in air at 37°C. Approximately 5  105
cells were seeded in 25-cm2 culture flasks and used after reaching
90% confluence, typically in 3 days (see Fig. 1, B and C). The cultures
maintained polarity with cells attached to the plastic by their basolat-
eral aspect (33), thus allowing ANG II access only to their luminal
surface. Cells were washed with PBS, pH 7.5, and immediately
incubated with DMEM in the absence of FBS and the different
compounds that are indicated in the figures. Cells were harvested and
lysed in a buffer containing 1 mM EDTA, 20 mM HEPES-Tris (pH
7.0), 250 mM sucrose, and 0.15 mg/ml trypsin inhibitor, using a
Potter-Elvejhem homogenizer with a teflon pestle. After protein con-
centration determination by the Lowry assay (29), lysates were kept
on ice and the further assays were carried out the same day for
Ca2-ATPase and PKC activities, and also for Western blotting
analysis of AT1R and AT2R after immunoprecipitation with specific
antibodies.
Measurements of Ca2-ATPase activities (SERCA and PMCA).
Ca2-ATPase activity was measured by colorimetric quantification of
inorganic phosphate (Pi) released from ATP (46). Total Ca2-ATPase
was calculated as the difference between the total activity and that
determined in the presence of 2 mM EGTA. SERCA activity was
taken as the fraction of total activity that was inhibited by 1 M
thapsigargin (the specific SERCA inhibitor), the remaining activity
being considered as PMCA catalysis. Activity was measured in a
solution containing 50 mM bis-Tris-propane buffer (pH 7.4), 5 mMFig. 1. A: ANG II effect via luminal membrane on calcium pumps in LLC-PK1
cells. ANG II stimulates SERCA activity (top open bars) and does not
modulate PMCA activity (bottom filled bars). Cells were incubated with
different ANG II concentrations (1014 to 106 M) for 30 min and Ca2-
ATPase activities were then measured. For details, see METHODS. Data bars
indicate means  SE of at least 4 determinations in triplicate using different
cell lysate preparations. *SERCA activities statistically different from the
control without ANG II (P  0.05). B–E: bright field microscopy of LLC-PK1
cells at 90% of confluence (B and C) and at 100% of confluence (D and E).
Fig. 2. Time course of ANG II effect on SERCA ( ) and PMCA (Œ) activities.
The luminal membranes of LLC-PK1 cells were exposed to 1010 M ANG II
during the times indicated on the abscissa before Ca2-ATPase activity was
determined. For details, see METHODS. Inset: ANG II effect SERCA ( ) and
PMCA (Œ) activities during the first 5 min for a better visualization. Data
points indicate means  SE of at least 4 determinations in triplicate using
different cell lysate preparations. *Statistically different from the control
without ANG II (P  0.05).
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ATP, 5 mM MgCl2, 10 mM NaN3, 120 mM KCl, 0.1 mM ouabain, 0.2
mM EGTA, and 7.5 M free Ca2. The total CaCl2 needed for the
desired free Ca2 concentration was calculated as in Ref. 45. Assays
were started by adding cell lysate (0.1 mg/ml protein) at 37°C and
stopped after 20 min by addition of 0.75 ml of activated charcoal in
0.1 M HCl. After centrifugation at 18,000 g to sediment the charcoal,
the amount of Pi released was measured in aliquots of 500 l of the
supernatants.
Determination of PKC activity. PKC activity was measured by the
incorporation of the -phosphoryl group from [-32P]ATP into his-
tone H8, which was used as substrate as described elsewhere (11).
About 5  105 cells were incubated with different ANG II concen-
trations for 30 min, in the absence or presence of 5  108 M
calphostin C (PKC inhibitor) that had been added to the culture 10
min before ANG II. After treatment, cell lysates and protein assays
were done as described above. PKC activity was measured in a
solution containing 4 mM MgCl2, 20 mM HEPES-Tris (pH 7.0), 12
mM NaF, 1 mM ouabain, 1.5 mg/ml histone H8, and 0.7 mg/ml
protein of cell lysates. Reaction was initiated by adding [-32P]ATP
(10 Ci/mmol). After 10 min at 37°C, the reaction was stopped by
adding 0.1 ml trichloroacetic acid (40% wt/vol). The content of each
tube was filtered through 0.45-m-pore Millipore filters, which were
successively washed with 20% trichloroacetic acid and phosphate
buffer (2 mM, pH 7.0) to remove unused [-32P]ATP. The radioac-
tivity incorporated into the histone was determined in a liquid scin-
tillation counter. PKC activity was calculated by the difference be-
tween the radioactivity incorporated into histone in the presence of
lysates originated in cells untreated or treated with calphostin C.
Immunoprecipitation and Western blotting for AT1R/AT2R het-
erodimers detection. Immunoprecipitation and Western blotting anal-
ysis were performed as previously described (5), with slight modifi-
cations. LLC-PK1 cells were incubated with different ANG II con-
Fig. 3. Prior exposure of the luminal membrane of LLC-PK1 cells to ANG II potentiates the ANG II-induced Ca2 mobilization from intracellular stores.
Increases in cytosolic Ca2 were measured by confocal microscopy using the Fluo-3/AM indicator as described in METHODS. A: Ca2 signals (left images) and
ImageJ analysis (right images) of the single cell indicated by red arrow at left, before (top) and after (bottom) exposure of the cells to 107 M ANG II. B: same
experiments as in A, except that the cells were preincubated with 109 M ANG II before stimulation with 107 M ANG II. C and D: averaged data (n 	 6) for
the Ca2 mobilization illustrated in A and B, respectively. The white bar represents 50 m. The points represent means  SE of the acquired fluorescence values
(see METHODS).
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centrations for 30 min at 37°C and cell lysates were obtained as
described above. Protein (1 mg/ml) was solubilized at room temper-
ature in 0.01% (wt/vol) CHAPS for 30 min, followed by incubation
with a mouse anti-AT1R monoclonal antibody (1:200) for 60 min at
4°C. Protein A/G-agarose was added and the mixture was left over-
night at 4°C under gentle agitation. Supernatants were separated from
the immunoprecipitates by centrifugation at 1,000 g for 5 min at 4°C,
and the resulting sediments were washed three times with Tris-
buffered saline (pH 7.6), mixed with Laemmli buffer, and heated at
100°C for 4 min to remove antibodies and protein A/G-agarose. After
centrifugation (16,100 g for 2 min at 4°C), supernatants containing the
receptors were submitted to electrophoresis (10% SDS-PAGE), trans-
ferred to nitrocellulose membranes, and probed with a rabbit poly-
clonal anti-AT2R antibody (1:500). The total protein was controlled
using Ponceau red staining after transfer to nitrocellulose membranes
to verify whether the same quantity of protein is present in all lanes.
After being stripped, the same membrane was probed for AT1R using
a rabbit polyclonal antibody. The 45-kDa band in the immunoprecipi-
tates detected with the AT1R polyclonal antibody was considered to
correspond to 100% of the receptors and this was the loading internal
control of receptors in each experiment. The AT2R/AT1R immunosig-
nal ratio in the same gel indicated the relative amount of AT2R/AT1R
heterodimers. The tiny band of 50 kDa probably corresponds to the
IgG heavy chain and no other bands were observed in the full
membrane.
Quantification of ANG II by high-performance liquid chromatography.
ANG II was measured after incubation with LLC-PK1 cells attached
to the culture flasks. ANG II (8 M) was incubated with cells for
different times (0, 30, 60, and 120 min) in a humidified atmosphere of
5% CO2 in air at 37°C. The supernatants were subsequently analyzed
by high-performance liquid chromatography (HPLC) as previously
described (5).
Measurement of intracellular Ca2 mobilization. To assess cyto-
solic Ca2 mobilization, LLC-PK1 cells were loaded with Fluo-3/AM
(1 M) at 37°C in a humidified incubator with 5% CO2 in air for 30
min in the absence or presence of 109 M ANG II. Cells were imaged
in buffer (135 mM NaCl, 5 mM KCl, 10 mM HEPES, 1 mM MgCl2,
2 mM glucose, 2 mM CaCl2; pH 7.2). Fluorescence imaging involved
the use of a scanning laser confocal microscope Leica SP5 (Leica)
with a 63 water immersion objective. Fluo-3 fluorescence dye was
excited at 488 nm with an argon ion laser, and the emitted fluores-
cence was measured at 510 nm. Digital image analyses were made
using ImageJ (available at http://rsb.info.nih.gov/ij). Time course
software was used to capture three-dimensional volume images of the
cells (zyt) in the Live Data Mode acquisition. Fluorescence values
were reported as 
F/F0, (
F 	 Ft  F0), where Ft is the observed
fluorescence at time t after stimulus with 107 M ANG II, and F0 is
the fluorescence at t 	 0. Ft and F0 were computed by adding the
intensity of the pixels in a circular area enclosing a single cell.
Experiments were carried out at room temperature (23–25°C).
Measurement of ACE, ACE2, neprilysin, and amino peptidases
activities in LLC-PK1 cells cultures. The activities of ACE, ACE2,
neprilysin (NEP), and amino peptidases (AP) were measured using
fluorescent substrates containing the fluorogenic group 4-methyl-
coumaryl-7-amide (MCA) or ortho-amino benzoic acid (Abz) and the
fluorescent suppressor groups dinitrophenyl (Dnp) or 2,4-dinitrophe-
nyl-ethylendiamino (EDDnp), in the absence or presence of the
inhibitors lisinopril (for ACE), thiorphan (for NEP), DX600 (for
ACE2), and bestatin (for AP), as previously described (6, 41). Briefly,
hydrolysis of substrates was monitored by spectrofluorimetry (Hitachi
F-4500, Tokyo, Japan). LLC-PK1 cells were plated in six-well plates
at 2 105 cells per well for 3 days in low-glucose DMEM (10% FBS)
with antibiotic supplements in a humidified atmosphere of 5% CO2 in
air at 37°C. After careful removal of the medium, the layers of 90%
confluent cells were supplied with HBSS buffer (140 mM NaCl, 5
mM KCl, 0.1 mM CaCl2, 0.63 mM MgSO4, 1 mM Na2HPO4, and 6.1
mM glucose; pH 7.4 adjusted with HCl) containing 10 M ZnCl2.
The fluorescent substrates were then added in absence or presence of
their inhibitors and incubated for different times and aliquots were
removed for the fluorimetric measurements. For assays using MCA-
APK(Dnp)-OH (ECA2), Abz-FRK(Dnp)P (ECA), and MCA-rRL-
EDDnp (NEP), ex and em were 320 and 420 nm, respectively. For
Phe-MCA (AP), ex and em were 380 and 460 nm, respectively. The
peptidase activities (in arbitrary units) are presented as the difference
between the hydrolysis in the absence and presence of the correspond-
ing inhibitors.
Statistical analysis. Statistical analyses used ANOVA with the
Newman-Keuls posttest. Statistical significance was set at P  0.05.
Data were analyzed using the GraphPad Prism 5.0 program.
Fig. 4. ANG II is internalized by the luminal membrane of LLC-PK1 cells.
Cells firmly attached by their basolateral aspect (33) were exposed to 8 M
ANG II for different times and the medium was carefully collected and
analyzed by high-performance liquid chromatography (HPLC), as described in
METHODS. A–D: representative HPLC chromatograms showing the decay of
ANG II without formation of shorter peptides. E: graphic representation of
remaining ANG II in culture medium after incubation with the cells at the
indicated times. Data points indicate means  SE. *Statistically different from
the starting ANG II concentration (P  0.05).
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RESULTS
Activation of SERCA by exposure of the luminal membrane
to ANG II. Figure 1A shows SERCA and PMCA activities in
membranes isolated 30 min after exposure of intact LLC-PK1
cells to ANG II from the luminal side. Lower concentrations of
ANG II (1014 to 1010 M) led to an increase of SERCA
activity by 100%, while higher concentrations (108 and
106 M) had no effect on pump catalysis (open bars in Fig.
1A). PMCA was unaffected by ANG II over the entire range of
concentrations (filled bars in Fig. 1A).
Figure 1, B and C, shows the bright field microscopy of
LLC-PK1 cells at 90% of confluence, which was the experi-
mental condition used in this study. It can be seen in a different
field of view (10 and 40) that they present the same
preserved monolayer structure with the same well-established
tight junctions encountered with 100% of confluence (Fig. 1, D
and E), thus preventing ANG II-containing medium from
accessing the basolateral membranes. The stimulatory effect of
1010 M ANG II on SERCA activity was exactly the same as
that found with 90% confluent cells with no influence on
PMCA (data not shown).
Time course of the luminal effect of ANG II. Activation of
SERCA by luminal exposure of LLC-PK1 cells to ANG II
(1010 M) is time-dependent (Fig. 2). After a short exposure of
30 s, ANG II had already stimulated SERCA activity, as
measured after isolation of membranes; this increase persisted
until 30 min of incubation. With luminal membranes of the
cells exposed to ANG II for 1 h, activation no longer occurred
(gray symbols). Except when otherwise noted, the following
experiments were therefore undertaken in membranes isolated
after exposure of LLC-PK1 cells to 1010 M ANG II for 30
min. PMCA was unaffected by ANG II at any of the incubation
times (Fig. 2, black symbols).
ANG II increases Ca2 mobilization in LLC-PK1 cells. To
investigate whether ANG II induces Ca2 mobilization in
LLC-PK1 cells, intracellular Ca2 was measured (Fig. 3). At
107 M, ANG II induced a transient increase in cytosolic Ca2
(Fig. 3, A and C). When the cells were pretreated with 109 M
ANG II for 30 min before stimulation with 107 M, the
increase was 10-fold higher, which was sustained for 3-fold
longer than in the absence of prior preincubation with 109 M
ANG II (Fig. 3, B and D).
ANG II is internalized by LLC-PK1 cells via luminal
membrane. A possible mechanism for ANG II-mediated
SERCA activation is the internalization of the peptide (36, 47)
or the formation of small ANG II-derived activating peptides
(5, 6). To test the hypothesis that ANG II is internalized or
partially metabolized, LLC-PK1 cells were incubated with 8
M ANG II for different times and the resulting supernatants
were analyzed by HPLC (Fig. 4). Representative HPLC chro-
matograms show a time-dependent decrease of medium ANG
II without the formation of metabolites.
ACE, ACE2, NEP, and AP are active in luminal membranes
of LLC-PK1 cells. Since there was a decrease in ANG II
concentration in the medium associated with no formation of
derived peptides, the activities of ACE, ACE2, NEP, and AP
were measured (Fig. 5). The hydrolysis of each corresponding
fluorescent substrates, Abz-FRK(Dnp)P for ACE (Fig. 5A),
Phe-MCA for AP (Fig. 5B), MCA-rRL-EDDnp for NEP (Fig.
5C), and MCA-APK(Dnp)-OH for ACE2 (Fig. 5D), indicates
the existence of active peptidases capable of hydrolyzing ANG
II in the luminal membrane of LLC-PK1 cells.
AT1 and AT2 receptors heterodimerize and are involved in
ANG II effect on SERCA. To determine which receptor is
involved in the ANG II effect on SERCA activity, LLC-PK1
cells were treated with AT1R and AT2R antagonists (1010 M
Fig. 5. Peptidase activities in the luminal-ori-
ented side of LLC-PK1 cells. The activities of
angiotensin-converting enzyme (ACE; A), amino
peptidases (AP; B), neprilysin (NEP; C), and
ACE2 (D) were measured in the presence of their
respective fluorescent substrates: 20 M Abz-
FRK(Dnp)P (for ACE), 46.5M Phe-MCA (for
AP), 20 M MCA-rRL-EDDnp (for NEP), and
40 M MCA-APK(Dnp)-OH (for ACE2). The
substrates and inhibitors were added to the me-
dium bathing the 90% confluent cells and ali-
quots were removed at 30 and 60 min for the
fluorimetric assays as described under METHODS.
The obtained values are expressed in fluores-
cence arbitrary units and represent the difference
between the hydrolysis in the absence and pres-
ence of their respective inhibitors: 1 M lisino-
pril (for ACE), 10M bestatin (for AP), 100 nM
thiorphan (for NEP), and 10 M DX600 (for
ACE2). Data bars indicate means  SE of at
least 2 determinations.
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losartan and 107 M PD123319, respectively), before incuba-
tion with ANG II (Fig. 6). Both agents blocked the ANG II
effect on SERCA. The two antagonists per se had no effect
and, as expected from the previous results, PMCA was not
modulated by any treatment (Fig. 6, inset). Thus, we investi-
gated whether ANG II via luminal membranes led to AT1R/
AT2R heterodimer formation that might explain why each
antagonist alone blocked SERCA stimulation. Immunoprecipi-
tation followed by Western blotting showed that the preexist-
ing population of AT1R/AT2R heterodimers increased by
140% after exposure of LLC-PK1 cells to 1010 and 106 M
ANG II (Fig. 7).
Signaling pathway stimulated by ANG II. The main signal-
ing pathway stimulated by ANG II in renal cells is the PLC/
PKC pathway (16, 39). To investigate whether these enzymes
are involved in the stimulation of SERCA mediated by ANG II
via luminal membranes of LLC-PK1 cells, the PLC inhibitor
U73122 and the PKC inhibitor calphostin C were added to the
culture medium 10 min before exposure of cells to ANG II.
U73122 and calphostin C blocked stimulation of SERCA
activity by ANG II (Figs. 8 and 9). PMCA was unaffected by
the inhibitors (Figs. 8, inset, and 9, inset). Furthermore,
SERCA activity was stimulated by 107 and 106 M PMA
(Fig. 10), mimicking to the same extent the ANG II effect, an
observation that confirms the participation of PKC in the
luminally triggered ANG II signaling pathway. PKC activity
from LLC-PK1 cells was measured in the lysate after exposure
of intact cells to ANG II, giving a biphasic response (Fig. 11).
Whereas 1010 M ANG II significantly stimulated the basal
PKC activity, there was a 50% inhibition at 106 M.
DISCUSSION
We demonstrated that SERCA is the target Ca2-ATPase for
luminal-oriented participation of ANG II in Ca2 homeostasis
in a lineage of proximal tubule cells. With LLC-PK1 cells
firmly and totally adherent to the wall of culture flasks or to
coverslips inside culture plates by their basolateral surfaces
(33), exposure to ANG II could only have been to their luminal
surfaces. The main initial points to be considered are 1) the
response elicited by ANG II on intact cells was preserved after
the 2-h period had elapsed from the end of incubation to the
recovery of lysates, 2) only the intracellular Ca2-ATPase was
modulated by luminal-oriented ANG II, with no influence on
the basolateral plasma membrane Ca2-ATPase, and 3) the
stimulus of SERCA observed in vitro with the use of lysates
(Fig. 1A) has a counterpart in the ANG II-induced transient
increase in cytosolic Ca2 observed with intact cells (Fig. 3).
Even though LLC-PK1 cell cultures are luminally oriented
without access of the medium to the basolateral aspect (Fig. 1,
B–E), they are not tubular structures. Despite this limitation,
the experiments here described also clearly demonstrate that
exposure of the luminal membrane of LLC-PK1 cells to ANG
II, at the physiological (nanomolar) concentrations described
by Navar and Nishiyama (36) in renal tubules, promotes a
Fig. 6. ANG II effect on SERCA activity from LLC-PK1 cells is mediated by
AT1 and AT2 receptors. The luminal membranes of the cells were preincubated
for 10 min with 1010 M losartan (Los) or 107 M PD123319 (PD) receptor
antagonists, before incubation with or without 1010 M ANG II for 30 min in
the combinations shown on the abscissa; then, Ca2-ATPase activity was
determined. Inset: PMCA activity. Data bars indicate means  SE of at least
4 determinations in triplicate using different cell lysate preparations. *Statis-
tically different from control in the absence of ANG II and from treatment with
ANG II  losartan or ANG II  PD123319 (P  0.05).
Fig. 7. ANG II promotes AT1R/AT2R heterodimers formation in LLC-PK1
cells. A: cells were incubated with or without ANG II for 30 min. Cell lysates
were immunoprecipitated with monoclonal anti-AT1R antibody and subse-
quently submitted to Western blotting using a polyclonal anti-AT2R antibody
(IP: AT1R ¡ WB: AT2R). After being stripped, membranes were probed with
polyclonal anti-AT1R antibody (IP: AT1R ¡ WB: AT1R). For details, see
METHODS. B: densitometric representation of the immunoreactive signals ratio
for AT2R and AT1R after immunoprecipitation of AT1R. Data bars indicate
means  SE using different cell lysate preparations. *Statistically different
from the control without ANG II (P  0.05).
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rapid and persistent stimulus of SERCA activity within 30 s
(Fig. 2). The earliness of the effect likely indicates a receptor-
dependent Ca2 release from endoplasmic reticulum (ER)
rather than a Ca2 leakage from the lumen of this organelle.
The stimulus of SERCA activity, and of coupled Ca2 trans-
port toward the ER lumen, appears to follow a previous ANG
II-induced Ca2 release. Since SERCA is the ATPase that
sustains Ca2 stock within the reticulum (12), its fast stimu-
lation by ANG II via luminal membrane may mean that
SERCA activation increases the Ca2 stock in the reticulum to
ensure more efficient Ca2 mobilization and, consequently, an
enhanced cellular response facing a new stimulus of ANG II.
This view is supported by measurements of intracellular Ca2
mobilization (Fig. 3), which demonstrate that there is an
increase of one order of magnitude in the peak of Ca2
mobilization induced by 107 M ANG II after a pretreatment
with 109 M ANG II (compare Fig. 3, A and C, with Fig. 3, B
and D). Therefore, we propose that enhanced intracellular
Ca2 waves and spikes promoted by tubular ANG II fluctua-
tions result from modulation of SERCA turnover and, there-
fore, of the Ca2 uptake/release cycles capable of amplifying
Fig. 8. Phospholipase C (PLC) is involved in the activation of SERCA by ANG
II facing the luminal membrane. Cells were exposed to U73122 (2  106 M)
for 10 min before addition of 1010 M ANG II as indicated on the abscissa.
Ca2-ATPase activities were measured after 30-min incubation. Inset: PMCA
activity. For details, see METHODS. Data bars indicate means  SE of at least
5 determinations in triplicate using different cell lysate preparations. *Statis-
tically different from the control in absence of ANG II and from treatment with
ANG II  U73122 (P  0.05).
Fig. 9. Exposure of the luminal membrane to ANG II stimulates SERCA
activity through a PKC signaling pathway. Cells were exposed to Calphostin
C (Cal-C; 5  108 M) for 10 min, as shown. Then, 1010 M ANG II was
added and 30 min later Ca2-ATPase activity was measured. Inset: PMCA
activity. For details, see METHODS. Data bars indicate means  SE of at least
6 determinations in triplicate using different cell lysate preparations. *Statis-
tically different from the control and from treatment with ANG II  Cal-C
(P  0.05).
Fig. 10. PMA mimics stimulation of SERCA activity by ANG II. Cells were
incubated with PMA (107 and 106 M) for 30 min and Ca2-ATPase activity
was then determined. Data bars indicate means  SE of at least 4 determina-
tions in triplicate using different cell lysate preparations. *Statistically different
from the control without PMA (P  0.05).
Fig. 11. Exposure of the luminal membrane to low concentration of ANG II
stimulates PKC activity in LLC-PK1 cells. ANG II (1010 or 106 M) was
added to the culture for 30 min and PKC activity was measured as described
in METHODS. Data bars indicate means  SE of at least 4 determinations in
triplicate using different cell lysate preparations. *P  0.05 with respect to
control without ANG II. #P  0.05 with respect to 1010 M ANG II.
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the efficiency of the regulatory responses triggered by ANG II.
The positive amplification of ANG II Ca2 mobilization that
has been demonstrated seems to be an important way for
luminal ANG II to regulate Ca2 homeostasis in renal cells,
and also Ca2-modulated fluid reabsorption in proximal tu-
bules (17). Positive feedbacks involving tubular and interstitial
ANG II have been proposed as key events in renal Na (and
fluid) balance (36).
The lack of a luminal effect of ANG II on PMCA activity
(Figs. 1 and 2), combined with our previous studies showing
inhibition of basolateral PMCA (46), demonstrates the sid-
edness of ANG II effects on Ca2 homeostasis in proximal
tubule cells, which appears to modulate Ca2 oscillations
through different pathways. Whereas basolateral ANG II in-
creases cytosolic Ca2 by inhibition of PMCA, the positively
self-sustained luminal stimulus on SERCA provides a refined
mechanism for further Ca2 control. It is noteworthy that,
despite their polarity, the ANG II effect on Ca2 homeostasis
in proximal tubule cells is biphasic concerning the agonist
concentration (5, 6) (Fig. 1); however, the processes involved
seem to be different. While counteracting effects on PMCA are
associated with limited proteolysis of ANG II with formation
of Ang-(3–4) (5), progressive suppression of luminal activa-
tion appears to be linked to internalization of the peptide
because its time-dependent decrease (Fig. 4) in the “luminal
compartment” occurs without detectable ANG II metabolites,
despite the presence of different active peptidases (ACE,
ACE2, NEP, and AP) in the luminal side of the LLC-PK1 cells
(Fig. 5). An important related observation is probably that the
biphasic and dose-dependent ANG II regulation on both lumi-
nal and peritubular sides of proximal tubule has also been
described with respect to proximal reabsorption of solutes and
fluid (17, 21, 23, 43).
This work provides evidence that the activation of SERCA
by luminal-oriented ANG II is sensitive to losartan and
PD123319 (Fig. 6), and therefore ANG receptors are involved.
This response is mediated by AT1R/AT2R heterodimers, a
formation that is increased by 100%, either at nano- or
micromolar ANG II concentrations (Fig. 7). Previous results of
our group showed that ANG II also acts via the AT1R/AT2R
heterodimer to initiate the specific signaling pathway that
culminates in inhibition of PMCA activity in basolateral mem-
branes (5). This seems to be a more widespread and relevant
phenomenon than previously thought. Dimerization may be a
necessary prerequisite in the induction of cell responses medi-
ated by G protein-coupled receptors (22, 31) involving ANG II
and bradykinin (13, 31), although the functionality of ANG
II receptor dimerization is not completely understood. After
binding to luminal receptors, internalized ANG II could rapidly
interact with its receptors in the ER (14) to stimulate SERCA
activity. Thus, it seems plausible that AT1R and AT2R in the
luminal and basolateral membranes of proximal tubule cells
(44, 49) are functionally connected with those found in organ-
elles (14, 52) to ensure the fine-tuning of cytosolic Ca2.
As in the case of inhibition of the basolateral PMCA (4, 5),
ANG II also activates the U73122-sensitive PLC ¡ DAG/
PMA-stimulated ¡ calphostin-inhibited PKC pathway (Figs.
811). However, in this case ANG II facing the luminal
membrane leads to the stimulus of SERCA pumping activity.
The experiments in Fig. 11 shed some light to the possible
mechanism by which the basal SERCA activity is recovered at
high ANG II concentrations (Fig. 1). Because heterodimer
formation is identical at 1010 and 106 M ANG II (Fig. 7), the
downregulation of SERCA stimulus at 106 M ANG II occurs
downstream of the receptors and may be due to a decrease in
PKC activity (Fig. 11).
In conclusion, exposure of the luminal membrane to ANG II
stimulates SERCA pumping activity in proximal tubule cells
by a mechanism that involves AT1R/AT2R dimerization and
activation of the PLC/PKC signaling pathway. These observa-
tions and those we previously reported demonstrate that ANG
II can modulate the Ca2 concentration in proximal tubule
cells in a bidirectional manner from both the luminal and the
basolateral side. Due to the relevance of Ca2 oscillations in
the control of fluid reabsorption, the concerted ANG II-medi-
ated effects on SERCA and PMCA in proximal tubules emerge
as a key feature in body fluid homeostasis.
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